secwatch.observer — SEC 8-K summary
======================================

Issuer:     Tango Therapeutics, Inc. (TNGX)
CIK:        0001819133
Form:       8-K
Filed at:   2025-10-24T23:59:59+00:00
Accession:  0001193125-25-249302
Event type: other_material
Sentiment:  neutral
Materiality: 0.70
Item codes: 1.01, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Tango Therapeutics raises ~$212M via registered direct offering and PIPE
------------------------------------------------------------------------

- Registered direct offering of 21.0M shares and 3.2M pre-funded warrants at $8.66; net proceeds ~$197M.
- Separate PIPE of 1.7M shares at $8.66 for ~$15M total gross proceeds.
- Proceeds to advance pipeline and general corporate purposes; cash runway extended into 2028.
- Closings expected October 24, 2025; customary conditions apply.
- Officers and directors to enter 60-day lock-up agreements per PIPE terms.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1819133/000119312525249302/0001193125-25-249302-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1819133/000119312525249302/d80580d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-249302

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer